Telix Pharmaceuticals Limited American Depositary Receipt (TLX)
Market Closed
3 Mar, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary $
6. 97
-0.08
-1.13%
$
2.43B Market Cap
- P/E Ratio
- Div Yield
175,513 Volume
- Eps
$ 7.05
Previous Close Day Range
6.69 6.99
Year Range
6.28 20
Want to track TLX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | 0.03 | 0.06 |
| | | 0.03 | - |
| | | - | 0.04 |
| | | - | - |
| | | - | 0.01 |
TLX Earnings Reports FAQ
What is the earnings per share (EPS) for TLX?
EPS data for TLX is currently not available, as Telix Pharmaceuticals Limited American Depositary Receipt has not reported recent earnings.
What is the company's earnings growth rate?
Telix Pharmaceuticals Limited American Depositary Receipt has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Telix Pharmaceuticals Limited American Depositary Receipt has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings were 0.06 per share, reported on 2026-02-20. For dividend history, visit the TLX Dividends page.
What is the price-to-earnings (P/E) ratio?
The price-to-earnings (P/E) ratio is 116.17, calculated based on the most recent stock price of $6.97.
